Exact Sciences
EXAS
#1708
Rank
ยฃ7.92 B
Marketcap
ยฃ42.84
Share price
1.13%
Change (1 day)
-17.50%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) Fails to deliver data

Key failure to deliver metrics for Exact Sciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exact Sciences (EXAS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exact Sciences (EXAS) - since 2013

Volume in USD (price x number of shares), data since 2013

Exact Sciences (EXAS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024ยฃ61.9 M43.71%
2023ยฃ43.07 M-0.26%
2022ยฃ43.18 M-13.64%
2021ยฃ50.01 M-29.41%
2020ยฃ70.84 M-66.29%
2019ยฃ0.21 B88.7%
2018ยฃ0.11 B89.93%
2017ยฃ58.64 M84.58%
2016ยฃ31.77 M-74.24%
2015ยฃ0.12 B-14.01%
2014ยฃ0.14 B2583.01%
2013ยฃ5.34 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ0.02 Mยฃ0.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aยฃ5.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.54 Mยฃ11.24 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.88 Mยฃ3.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.64 Mยฃ71.88 M๐Ÿ‡ซ๐Ÿ‡ท France